BIO-UV Group Balance Sheet Health
Financial Health criteria checks 4/6
BIO-UV Group has a total shareholder equity of €32.4M and total debt of €27.4M, which brings its debt-to-equity ratio to 84.6%. Its total assets and total liabilities are €74.1M and €41.7M respectively. BIO-UV Group's EBIT is €4.1M making its interest coverage ratio 6.3. It has cash and short-term investments of €2.0M.
Key information
84.6%
Debt to equity ratio
€27.38m
Debt
Interest coverage ratio | 6.3x |
Cash | €1.98m |
Equity | €32.35m |
Total liabilities | €41.74m |
Total assets | €74.10m |
Recent financial health updates
Recent updates
Returns On Capital Are Showing Encouraging Signs At BIO-UV Group (EPA:ALTUV)
Mar 16Is There An Opportunity With BIO-UV Group S.A.'s (EPA:ALTUV) 48% Undervaluation?
Dec 02BIO-UV Group (EPA:ALTUV) Is Doing The Right Things To Multiply Its Share Price
Jun 10Need To Know: Analysts Just Made A Substantial Cut To Their BIO-UV Group S.A. (EPA:ALTUV) Estimates
Apr 09Investors Still Waiting For A Pull Back In BIO-UV Group S.A. (EPA:ALTUV)
Jun 16The Return Trends At BIO-UV Group (EPA:ALTUV) Look Promising
Feb 25BIO-UV Group's (EPA:ALTUV) Earnings Are Weaker Than They Seem
Sep 30Returns At BIO-UV Group (EPA:ALTUV) Are On The Way Up
May 22Investors Who Bought BIO-UV Group (EPA:ALTUV) Shares A Year Ago Are Now Up 87%
Jan 11Is BIO-UV Group S.A. (EPA:ALTUV) Trading At A 48% Discount?
Nov 18Financial Position Analysis
Short Term Liabilities: ALTUV's short term assets (€31.0M) exceed its short term liabilities (€18.8M).
Long Term Liabilities: ALTUV's short term assets (€31.0M) exceed its long term liabilities (€23.0M).
Debt to Equity History and Analysis
Debt Level: ALTUV's net debt to equity ratio (78.5%) is considered high.
Reducing Debt: ALTUV's debt to equity ratio has reduced from 94% to 84.6% over the past 5 years.
Debt Coverage: ALTUV's debt is not well covered by operating cash flow (9.8%).
Interest Coverage: ALTUV's interest payments on its debt are well covered by EBIT (6.3x coverage).